This is what PAC Partners said- back in 2021 , a lot has happened since then and I suspect that it (26% of GLE may be worth more than tey said now?
:
Silex Systems Limited (ASX:SLX)
The global laser separation leader
KEY POINTS
• SLX has full ownership and 51% control of the next generation of Uranium enrichment. #1 Nth American Cameco is the 49% partner.
• SLX’s global leadership in this laser separation technology also has short term commercial applications to Zero Spin Silicon for supercomputers which SLX can develop with its own funding.
• We see SLX generating positive cash flow from 2025 from non-uranium applications, and owning 25% of Paducah Ur Mine by 2030.
• This should deliver a base EBITDA of $70m, and provide a platform for multiple uranium and other laser separation applications.
• SLX can choose to fund this development with its $20m cash and equity agreements with global partners.
• After key 2021/22 milestones, SLX has many funding options to accelerate additional applications and control commercial outcomes.
STEPS TO CONTROL OF TECHNOLOGY AND EQUITY
In January 2021 SLX earned the right to 51% of Global Laser Enrichment (GLE), and can now secure the approval for the Paducah uranium mine.
SLX has an option to sell 26% of its ownership of GLE to Cameco at any time from Demonstration Plant to Paducah design and construction.
We assume the sale will be done in 2025 for US$203m. This is a 50% premium to the US$125m paid for 24% of GLE in 2008, when GLE did not own the Paducah Tailings for a 30 year mine of 5.2mlb U308 with approval. We assume this sale allows SLX to pay a A$65m dividend, fund its 25% of the Paducah Mine, and pitch for other uranium enrichment projects
![]()
PAC Research Report on Silex.pdf
- Forums
- ASX - By Stock
- SLX
- 30th June 2023 Share Price Prediction
SLX
silex systems limited
Add to My Watchlist
2.25%
!
$4.34

30th June 2023 Share Price Prediction, page-87
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.34 |
Change
-0.100(2.25%) |
Mkt cap ! $1.033B |
Open | High | Low | Value | Volume |
$4.54 | $4.61 | $4.32 | $3.963M | 895.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16533 | $4.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 3059 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1162 | 4.310 |
1 | 338 | 4.260 |
1 | 1185 | 4.210 |
2 | 22090 | 4.200 |
1 | 1130 | 4.180 |
Price($) | Vol. | No. |
---|---|---|
4.410 | 28344 | 1 |
4.520 | 571 | 1 |
4.560 | 800 | 1 |
4.570 | 11982 | 1 |
4.580 | 25000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online